Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DNN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,878
Award facts
- Contract value 100% obligated
- $21,877.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,877.83 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Dupixent 200 mg/1.14 mL pen injectors. This firm fixed-price, non-set-aside contract is scheduled for completion by January 21, 2026, with performance at the vendor's Conshohocken, Pennsylvania location. The order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Dupixent, a prescription biologic used primarily for eczema, asthma, and other allergic conditions, reflects the company's established role in supplying specialized pharmaceutical commodities to the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9DNN?
SPE2DR26F9DNN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9DNN worth?
The government has obligated $21,878 on SPE2DR26F9DNN.
Is contract SPE2DR26F9DNN an order under another contract?
Yes. SPE2DR26F9DNN is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DNN competed?
The extent of competition for SPE2DR26F9DNN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award